JP2015525771A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015525771A5 JP2015525771A5 JP2015523114A JP2015523114A JP2015525771A5 JP 2015525771 A5 JP2015525771 A5 JP 2015525771A5 JP 2015523114 A JP2015523114 A JP 2015523114A JP 2015523114 A JP2015523114 A JP 2015523114A JP 2015525771 A5 JP2015525771 A5 JP 2015525771A5
- Authority
- JP
- Japan
- Prior art keywords
- oligosaccharide
- antibody
- subject
- protein
- rha
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 0 CC([C@@](C(C1OC(OC(CO)C(C2O)O)=C2O)O)O)O[C@]1OCC([C@](C(C1O)O)O)O[C@@]1O[C@@](C(CO)O[C@@](C1*)O*)C1O[C@@](C1O)OC(CO[C@](C(C2O)O)OC(CO)[C@]2O)C(O)=C1O Chemical compound CC([C@@](C(C1OC(OC(CO)C(C2O)O)=C2O)O)O)O[C@]1OCC([C@](C(C1O)O)O)O[C@@]1O[C@@](C(CO)O[C@@](C1*)O*)C1O[C@@](C1O)OC(CO[C@](C(C2O)O)OC(CO)[C@]2O)C(O)=C1O 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261671898P | 2012-07-16 | 2012-07-16 | |
| US61/671,898 | 2012-07-16 | ||
| PCT/US2013/049203 WO2014014670A1 (en) | 2012-07-16 | 2013-07-03 | Synthetic oligosaccharides for p. aeruginosa vaccine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2015525771A JP2015525771A (ja) | 2015-09-07 |
| JP2015525771A5 true JP2015525771A5 (enExample) | 2016-08-18 |
Family
ID=49949172
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015523114A Pending JP2015525771A (ja) | 2012-07-16 | 2013-07-03 | 緑膿菌ワクチンのための合成オリゴ糖 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20150152129A1 (enExample) |
| EP (1) | EP2884842A4 (enExample) |
| JP (1) | JP2015525771A (enExample) |
| HK (1) | HK1211795A1 (enExample) |
| WO (1) | WO2014014670A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2014284457A1 (en) * | 2013-07-03 | 2016-01-28 | Visterra, Inc. | Synthetic oligosaccharides for P. aeruginosa vaccine |
| AU2016248452B2 (en) * | 2015-04-16 | 2018-05-31 | Inventprise, Inc. | Bordetella pertussis immunogenic vaccine compositions |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4693891A (en) * | 1985-09-09 | 1987-09-15 | Miles Laboratories, Inc. | Vaccine for Pseudomonas aeruginosa |
| US5866132A (en) * | 1995-06-07 | 1999-02-02 | Alberta Research Council | Immunogenic oligosaccharide compositions |
| US6248329B1 (en) * | 1998-06-01 | 2001-06-19 | Ramaswamy Chandrashekar | Parasitic helminth cuticlin nucleic acid molecules and uses thereof |
| CN101912609B (zh) * | 2009-08-20 | 2012-02-01 | 成都蓉生药业有限责任公司 | 防治绿脓杆菌感染的组合物及其制备方法 |
| WO2011133227A2 (en) * | 2010-04-23 | 2011-10-27 | Ancora Pharmaceuticals Inc. | Synthetic oligosaccharides for staphyloccocus vaccine |
| WO2012082635A1 (en) * | 2010-12-13 | 2012-06-21 | Ancora Pharmaceuticals, Inc. | Synthetic oligosaccharide group a streptococcus |
-
2013
- 2013-07-03 EP EP13819921.1A patent/EP2884842A4/en not_active Withdrawn
- 2013-07-03 JP JP2015523114A patent/JP2015525771A/ja active Pending
- 2013-07-03 WO PCT/US2013/049203 patent/WO2014014670A1/en not_active Ceased
- 2013-07-03 HK HK15112712.5A patent/HK1211795A1/xx unknown
- 2013-07-03 US US14/414,971 patent/US20150152129A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI425951B (zh) | 共軛方法 | |
| US10335468B2 (en) | Immunotherapeutic compositions for the treatment of alzheimer's disease | |
| JP2011042693A5 (enExample) | ||
| TW202112392A (zh) | 包含結合之莢膜醣抗原的免疫原組合物及其用途 | |
| JP2011079849A (ja) | ニコチン中毒の治療及び予防のためのハプテン−キャリア複合体 | |
| JP6773830B2 (ja) | 治療において使用するための免疫原性組成物 | |
| CN103497255B (zh) | 作为疟疾疫苗的恶性疟原虫表面蛋白的偶联物 | |
| RU2014122163A (ru) | Комбинации, включающие сахарид пневмококка серотипа 14 | |
| JP2015510872A (ja) | Ｓｔｒｅｐｔｏｃｏｃｃｕｓｐｎｅｕｍｏｎｉａｅ抗原の増強された製剤 | |
| KR20120052906A (ko) | 알부민-아밀로이드 펩타이드 컨주게이트 및 그의 용도 | |
| KR102077876B1 (ko) | Ｃｒｍ１９７ 담체 단백질에 커플링된 ｈｉｖ ｇｐ４１ 펩티드를 포함하는 면역원성 화합물 | |
| TW201345927A (zh) | 組成物 | |
| JP5661744B2 (ja) | 腸球菌由来のポリペプチド、及びワクチン接種のためのその使用 | |
| JP2016525507A5 (enExample) | ||
| JP2015525771A5 (enExample) | ||
| AU2025205220A1 (en) | Vaccine polypeptide compositions and methods | |
| US10590178B2 (en) | Chimeric vaccine against fungal infections | |
| AU2015359503B2 (en) | Method of treatment | |
| HK40056005A (en) | Vaccine polypeptide compositions and methods | |
| Messner et al. | Zina Mosleh* and Frank M. Unger | |
| EA048146B1 (ru) | Композиции поливалентной пневмококковой вакцины, содержащие конъюгаты полисахарид-белок |